Related references
Note: Only part of the references are listed.Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry
David C. A. Neville et al.
PROTEIN SCIENCE (2009)
Analysis of protein phosphorylation on a proteome-scale
Mark O. Collins et al.
PROTEOMICS (2007)
Unraveling the mechanisms of endocrine resistance in breast cancer: New therapeutic opportunities
Suleiman Massarweh et al.
CLINICAL CANCER RESEARCH (2007)
Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry
Henrik Molina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity
Varsha S. Likhite et al.
MOLECULAR ENDOCRINOLOGY (2006)
Huntingtin phosphorylation sites mapped by mass spectrometry - Modulation of cleavage and toxicity
Birgit Schilling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
被撤回的出版物: Activation function-1 domain of estrogen receptor regulates the agonistic and antagonistic actions of tamoxifen (Retracted Article. See vol 22, pg 772, 2008)
S Glaros et al.
MOLECULAR ENDOCRINOLOGY (2006)
Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth
D. J. Britton et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Identification by mass spectrometry and functional characterization of two phosphorylation sites of KCNQ2/KCNQ3 channels
TS Surti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations
DN Lavery et al.
BIOCHEMICAL JOURNAL (2005)
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
JM Gee et al.
ENDOCRINE-RELATED CANCER (2005)
Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
MC Gutierrez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: Who will have the last word?
CA Lange
MOLECULAR ENDOCRINOLOGY (2004)
Large-scale characterization of HeLa cell nuclear phosphoproteins
SA Beausoleil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Analysis of protein phosphorylation by hypothesis-driven multiple-stage mass spectrometry
EJ Chang et al.
ANALYTICAL CHEMISTRY (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
R Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Phosphoproteomic analysis of the developing mouse brain
BA Ballif et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells
IR Hutcheson et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity
LA deGraffenried et al.
ANNALS OF ONCOLOGY (2003)
Estrogen receptor phosphorylation
DA Lannigan
STEROIDS (2003)
Transactivation functions of the N-terminal domains of nuclear hormone receptors: Protein folding and coactivator interactions
R Kumar et al.
MOLECULAR ENDOCRINOLOGY (2003)
A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies - Identification of a novel protein, Frigg, as a protein kinase A substrate
M Gronborg et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
The N-terminal regions of estrogen receptor α and β are unstructured in vitro and show different TBP binding properties
A Wärnmark et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Estrogen receptor and breast cancer
S Sommer et al.
SEMINARS IN CANCER BIOLOGY (2001)
Rsk2 allosterically activates estrogen receptor α by docking to the hormone-binding domain
DE Clarkl et al.
EMBO JOURNAL (2001)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)